Cabergoline is a drug from which country?
Cabergoline (Cabergoline) is a drug widely used to treat hyperprolactinemia and Parkinson's disease. It inhibits the secretion of prolactin by acting on dopamine receptors in the brain, and can effectively relieve symptoms caused by excessive prolactin, such as irregular menstruation, infertility, and breast lumps. In addition, cabergoline also plays an important role in the treatment of Parkinson's disease, which can improve patients' motor symptoms and improve their quality of life. So, which company manufactures cabergoline?

The original drug of cabergoline was originally developed and launched by the Italian pharmaceutical company Ancoli (Advanced Accelerator Applications, referred to as AAA). Ankoli is a company that focuses on the research and development of innovative drugs. Cabergoline, as an important drug of the company, has been widely used around the world. Although the research and development of cabergoline began in Italy, as the demand for the drug in the market continued to increase, many pharmaceutical companies began to produce generic versions of cabergoline, allowing generic versions of cabergoline to enter markets around the world.
It is worth noting that although Ankoli initially developed cabergoline, Pfizer (Pfizer), as one of the world's leading pharmaceutical companies, is also involved in the production and sales of cabergoline in many countries and regions. Pfizer is a world-renowned multinational pharmaceutical company with strong R&D and production capabilities. In many countries, Pfizer's subsidiaries produce and sell generic and original versions of cabergoline, making the drug more widely available.
Pfizer not only ensures the global supply of cabergoline, but also provides drug options of different specifications in many countries, allowing patients to choose the most suitable dosage and treatment plan under the guidance of doctors. This is an important safeguard for patients who require long-term treatment.
Reference materials:https://my.clevelandclinic.org/health/drugs/20863-cabergoline-tablets
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)